MedPath

Exploring the Link Between Sleep and Brain Clearance

Not Applicable
Conditions
Healthy Aging
Interventions
Behavioral: Auditory Stimulation
Behavioral: Sham (no stimulation)
Registration Number
NCT05539378
Lead Sponsor
University Children's Hospital, Zurich
Brief Summary

The purpose of this study is to assess the link between sleep and the clearance of waste products from the brain. This will be assessed in a group of healthy older adults.

Detailed Description

First, the investigators want to assess the relationship between sleep parameters and markers for brain clearance, assessed with MRI and blood samples. Second, the investigators want to probe whether associations can be influenced by modulation of sleep parameters by means of auditory stimulation.

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Participation in previous longitudinal cohort studies at the study site
  • Ability to provide written and verbal informed consent
  • Fluency in the German language
  • Stable home situation that allows for reliable application of the intervention for the duration of the study
  • Ability to apply the intervention for the duration of the study, either alone or with support from a co-habitant
  • For women: Hormonal contraception, if menstrual cycle is still present or has been present within a year
  • Good general health status, normal cognitive function
Exclusion Criteria
  • Failure or inability to give informed consent
  • Inability to follow the procedures of the investigation
  • For women: pregnancy or breastfeeding
  • Presence of sleep disorders (e.g. sleep apnoea, narcolepsy, restless leg syndrome, insomnia, rapid eye movement (REM) sleep disorder)
  • Shift-work or a home situation that requires several awakenings during the night (e.g. newborn)
  • History of serious illness likely to interfere with study outcomes
  • Presence or history of a diagnosed neuropsychiatric illness
  • Current diagnosis of uncontrolled or poorly controlled diabetes
  • Current cancer of the brain or unstable cancer undergoing treatment
  • Evidence of serious atherosclerotic cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Auditory StimulationAuditory StimulationAuditory Stimulation during sleep
No Auditory StimulationSham (no stimulation)Playing no tones during sleep but still recording brain activity
Primary Outcome Measures
NameTimeMethod
Correlation between EEG slow wave activity (uV) and beta-amyloid (pg/ml)2 weeks
Correlation between EEG slow wave activity (uV) and diffusivity (mm2/s) from diffusion MRI2 weeks
Correlation between EEG slow wave activity (uV) and perfusion (ml/min/100 ml) from arterial spin labelling MRI2 weeks
Correlation between EEG slow wave activity (uV) and cerebrospinal fluid flow (ml/min) from phase contrast MRI2 weeks
Correlation between EEG slow wave activity (uV) and tau (pg/ml)2 weeks
Secondary Outcome Measures
NameTimeMethod
Correlation between EEG slow wave activity (uV) and attention, assessed with the Trail Making Test (time to completion)2 weeks
Correlation between EEG slow wave activity (uV) and C-Reactive Protein (mg/L), assessed from a blood sample2 weeks
Correlation between EEG slow wave activity (uV) and TNF-alpha (pg/L), assessed from a blood sample2 weeks
Correlation between EEG slow wave activity (uV) and memory function, assessed with the Hopkins Verbal Learning Test (memory score)2 weeks
Correlation between EEG slow wave activity (uV) and interleukins (pg/L), assessed from a blood sample2 weeks
Correlation between EEG slow wave activity (uV) and neuro-metabolite levels (mmol) from magnetic resonance spectroscopy2 weeks
Correlation between EEG slow wave activity (uV) and sleepiness, assessed with the Epworth Sleepiness Scale questionnaire2 weeks
Correlation between EEG slow wave activity (uV) and executive function (summary score, dimensionless)2 weeks
Correlation between EEG slow wave activity (uV) and fatigue, assessed via the fatigue severity scale (FSS) questionnaire2 weeks

Trial Locations

Locations (1)

Institute for Regenerative Medicine, University Hospital Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath